Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
Resmed Inc has filed a Form 144 notice indicating a proposed sale of common stock under Rule 144 of the Securities Act of 1933. The notice reports that Michael J. Rider, an officer of the company, plans to sell 64 shares of Resmed’s common stock valued at approximately $15,514.88. This transaction follows previous sales made by Rider in December 2024 and January 2025. The market impact of these sales is minimal given the limited number of shares involved relative to the total outstanding shares. However, such insider transactions are often monitored by investors for potential insights into the company’s future prospects.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc is a company operating in the healthcare industry, primarily focused on developing and manufacturing equipment for the treatment of sleep disorders, particularly sleep apnea. The company offers a range of products including devices, masks, and accessories designed to improve the quality of sleep and enhance breathing for patients.
YTD Price Performance: 9.27%
Average Trading Volume: 885,933
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$56.68B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.
